MindBio Therapeutics (XCNQ:MBIO) Days Sales Outstanding : 10.93 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Days Sales Outstanding?

MindBio Therapeutics's average Accounts Receivable for the three months ended in Mar. 2024 was C$0.05 Mil. MindBio Therapeutics's Revenue for the three months ended in Mar. 2024 was C$0.38 Mil. Hence, MindBio Therapeutics's Days Sales Outstanding for the three months ended in Mar. 2024 was 10.93.

The historical rank and industry rank for MindBio Therapeutics's Days Sales Outstanding or its related term are showing as below:

XCNQ:MBIO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0 Med: 0 Max: 15.29
Current: 15.29

During the past 3 years, MindBio Therapeutics's highest Days Sales Outstanding was 15.29. The lowest was 0.00. And the median was 0.00.

XCNQ:MBIO's Days Sales Outstanding is ranked better than
93.08% of 882 companies
in the Biotechnology industry
Industry Median: 72.545 vs XCNQ:MBIO: 15.29

MindBio Therapeutics's Days Sales Outstanding increased from Mar. 2023 (0.00) to Mar. 2024 (10.93).

MindBio Therapeutics Days Sales Outstanding Historical Data

The historical data trend for MindBio Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Days Sales Outstanding Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Days Sales Outstanding

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial					-	-	-	-	10.93

Competitive Comparison of MindBio Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, MindBio Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindBio Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindBio Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where MindBio Therapeutics's Days Sales Outstanding falls into.

MindBio Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

MindBio Therapeutics's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

MindBio Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	0.046)	/	1 )	/	0.384	*	365 / 4
=	0.046					/	0.384	*	365 / 4
=	10.93

MindBio Therapeutics (XCNQ:MBIO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

MindBio Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.